DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml

BACKGROUND: This study investigated the diagnostic utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) parameters for distinguishing between benign and malignant prostate tumors when serum prostate-specific antigen (PSA) level is ≥10 ng/ml....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hongmei, Du, Fengli, Liu, Yan, Li, Qian, Liu, Xinai, Wang, Tongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792168/
https://www.ncbi.nlm.nih.gov/pubmed/36578948
http://dx.doi.org/10.3389/fonc.2022.925186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792168/
https://www.ncbi.nlm.nih.gov/pubmed/36578948
http://dx.doi.org/10.3389/fonc.2022.925186

Ejemplares similares